Literature DB >> 26276566

Analysis of B-Raf[Formula: see text] inhibitors using 2D and 3D-QSAR, molecular docking and pharmacophore studies.

Reza Aalizadeh1, Eslam Pourbasheer2, Mohammad Reza Ganjali3,4.   

Abstract

In the present work, a molecular modeling study was carried out using 2D and 3D quantitative structure-activity relationships for the various series of compounds known as B-Raf[Formula: see text] inhibitors. For 2D-QSAR analysis, a linear model was developed by MLR based on GA-OLS with appropriate results [Formula: see text], which was validated by several external validation techniques. To perform a 3D-QSAR analysis, CoMFA and CoMSIA methods were used. The selected CoMFA model could provide reliable statistical values [Formula: see text] based on the training set in the biases of the selected alignment. Using the same selected alignment, a statistically reliable CoMSIA model, out of thirty-one different combinations, was also obtained [Formula: see text]. The predictive accuracy of the derived models was rigorously evaluated with the external test set of nineteen compounds based on several validation techniques. Molecular docking simulations and pharmacophore analyses were also performed to derive the true conformations of the most potent inhibitors with B-Raf[Formula: see text] kinase.

Entities:  

Keywords:  3D-QSAR; B-Raf kinase; Drug design; Molecular docking; Pharmacophore

Mesh:

Substances:

Year:  2015        PMID: 26276566     DOI: 10.1007/s11030-015-9626-y

Source DB:  PubMed          Journal:  Mol Divers        ISSN: 1381-1991            Impact factor:   2.943


  38 in total

Review 1.  Acquired and intrinsic BRAF inhibitor resistance in BRAF V600E mutant melanoma.

Authors:  Inna V Fedorenko; Kim H T Paraiso; Keiran S M Smalley
Journal:  Biochem Pharmacol       Date:  2011-05-25       Impact factor: 5.858

2.  Design and synthesis of 6,6-fused heterocyclic amides as raf kinase inhibitors.

Authors:  Savithri Ramurthy; Abran Costales; Johanna M Jansen; Barry Levine; Paul A Renhowe; Cynthia M Shafer; Sharadha Subramanian
Journal:  Bioorg Med Chem Lett       Date:  2011-12-30       Impact factor: 2.823

3.  LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters.

Authors:  Gerhard Wolber; Thierry Langer
Journal:  J Chem Inf Model       Date:  2005 Jan-Feb       Impact factor: 4.956

4.  QSAR modeling: where have you been? Where are you going to?

Authors:  Artem Cherkasov; Eugene N Muratov; Denis Fourches; Alexandre Varnek; Igor I Baskin; Mark Cronin; John Dearden; Paola Gramatica; Yvonne C Martin; Roberto Todeschini; Viviana Consonni; Victor E Kuz'min; Richard Cramer; Romualdo Benigni; Chihae Yang; James Rathman; Lothar Terfloth; Johann Gasteiger; Ann Richard; Alexander Tropsha
Journal:  J Med Chem       Date:  2014-01-06       Impact factor: 7.446

5.  Predicting antiprotozoal activity of benzyl phenyl ether diamine derivatives through QSAR multi-target and molecular topology.

Authors:  Ramon Garcia-Domenech; Riccardo Zanni; Maria Galvez-Llompart; Jorge Galvez
Journal:  Mol Divers       Date:  2015-03-10       Impact factor: 2.943

6.  Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity.

Authors:  G Klebe; U Abraham; T Mietzner
Journal:  J Med Chem       Date:  1994-11-25       Impact factor: 7.446

7.  Pyrazolopyridine inhibitors of B-RafV600E. Part 2: structure-activity relationships.

Authors:  Steve Wenglowsky; Kateri A Ahrendt; Alex J Buckmelter; Bainian Feng; Susan L Gloor; Stefan Gradl; Jonas Grina; Joshua D Hansen; Ellen R Laird; Paul Lunghofer; Simon Mathieu; David Moreno; Brad Newhouse; Li Ren; Tyler Risom; Joachim Rudolph; Jeongbeob Seo; Hillary L Sturgis; Walter C Voegtli; Zhaoyang Wen
Journal:  Bioorg Med Chem Lett       Date:  2011-07-02       Impact factor: 2.823

Review 8.  The role of B-RAF in melanoma.

Authors:  Vanessa C Gray-Schopfer; Silvy da Rocha Dias; Richard Marais
Journal:  Cancer Metastasis Rev       Date:  2005-01       Impact factor: 9.264

9.  Non-oxime inhibitors of B-Raf(V600E) kinase.

Authors:  Li Ren; Steve Wenglowsky; Greg Miknis; Bryson Rast; Alex J Buckmelter; Robert J Ely; Stephen Schlachter; Ellen R Laird; Nikole Randolph; Michele Callejo; Matthew Martinson; Sarah Galbraith; Barbara J Brandhuber; Guy Vigers; Tony Morales; Walter C Voegtli; Joseph Lyssikatos
Journal:  Bioorg Med Chem Lett       Date:  2010-12-19       Impact factor: 2.823

10.  AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility.

Authors:  Garrett M Morris; Ruth Huey; William Lindstrom; Michel F Sanner; Richard K Belew; David S Goodsell; Arthur J Olson
Journal:  J Comput Chem       Date:  2009-12       Impact factor: 3.376

View more
  3 in total

1.  Development of QSAR model for predicting the inclusion constants of organic chemicals with α-cyclodextrin.

Authors:  Mengbi Wei; Xianhai Yang; Peter Watson; Feifei Yang; Huihui Liu
Journal:  Environ Sci Pollut Res Int       Date:  2018-04-17       Impact factor: 4.223

2.  QSAR modeling and in silico design of small-molecule inhibitors targeting the interaction between E3 ligase VHL and HIF-1α.

Authors:  Jing Pan; Yanmin Zhang; Ting Ran; Anyang Xu; Xin Qiao; Lingfeng Yin; Weineng Zhou; Lu Zhu; Junnan Zhao; Tao Lu; Yadong Chen; Yulei Jiang
Journal:  Mol Divers       Date:  2017-07-08       Impact factor: 2.943

3.  Molecular Modeling Studies on Carbazole Carboxamide Based BTK Inhibitors Using Docking and Structure-Based 3D-QSAR.

Authors:  Rui Li; Yongli Du; Zhipei Gao; Jingkang Shen
Journal:  Int J Mol Sci       Date:  2018-04-19       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.